Free Trial

Shoulder Innovations (SI) Competitors

Shoulder Innovations logo
$14.02 +0.02 (+0.14%)
As of 11:16 AM Eastern

SI vs. COIN, INSP, KMTS, BLFS, and IRMD

Should you buy Shoulder Innovations stock or one of its competitors? MarketBeat compares Shoulder Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shoulder Innovations include Coinbase Global (COIN), Inspire Medical Systems (INSP), Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), and iRadimed (IRMD).

How does Shoulder Innovations compare to Coinbase Global?

Coinbase Global (NASDAQ:COIN) and Shoulder Innovations (NYSE:SI) are related companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

In the previous week, Coinbase Global had 68 more articles in the media than Shoulder Innovations. MarketBeat recorded 70 mentions for Coinbase Global and 2 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.63 beat Shoulder Innovations' score of 0.00 indicating that Coinbase Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Coinbase Global
29 Very Positive mention(s)
10 Positive mention(s)
14 Neutral mention(s)
8 Negative mention(s)
4 Very Negative mention(s)
Positive
Shoulder Innovations
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Coinbase Global has a net margin of 12.20% compared to Shoulder Innovations' net margin of -81.78%. Coinbase Global's return on equity of 4.16% beat Shoulder Innovations' return on equity.

Company Net Margins Return on Equity Return on Assets
Coinbase Global12.20% 4.16% 2.07%
Shoulder Innovations -81.78%-35.11%-20.58%

68.8% of Coinbase Global shares are owned by institutional investors. 16.7% of Coinbase Global shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Coinbase Global presently has a consensus price target of $250.81, indicating a potential upside of 50.52%. Shoulder Innovations has a consensus price target of $21.00, indicating a potential upside of 49.79%. Given Coinbase Global's higher probable upside, research analysts clearly believe Coinbase Global is more favorable than Shoulder Innovations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Coinbase Global
3 Sell rating(s)
11 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.48
Shoulder Innovations
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Coinbase Global has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Coinbase Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coinbase Global$7.18B6.11$1.26B$2.6662.64
Shoulder Innovations$47.32M6.14-$40.36M-$166.96N/A

Summary

Coinbase Global beats Shoulder Innovations on 12 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Inspire Medical Systems has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.23$145.42M$4.498.67
Shoulder Innovations$47.32M6.14-$40.36M-$166.96N/A

In the previous week, Inspire Medical Systems had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 3 mentions for Inspire Medical Systems and 2 mentions for Shoulder Innovations. Inspire Medical Systems' average media sentiment score of 0.95 beat Shoulder Innovations' score of 0.00 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Shoulder Innovations
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspire Medical Systems has a net margin of 14.33% compared to Shoulder Innovations' net margin of -81.78%. Inspire Medical Systems' return on equity of 10.35% beat Shoulder Innovations' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
Shoulder Innovations -81.78%-35.11%-20.58%

94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Inspire Medical Systems currently has a consensus target price of $81.84, suggesting a potential upside of 110.34%. Shoulder Innovations has a consensus target price of $21.00, suggesting a potential upside of 49.79%. Given Inspire Medical Systems' higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Shoulder Innovations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05
Shoulder Innovations
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Summary

Inspire Medical Systems beats Shoulder Innovations on 11 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to Kestra Medical Technologies?

Shoulder Innovations (NYSE:SI) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Shoulder Innovations and Shoulder Innovations both had 2 articles in the media. Kestra Medical Technologies' average media sentiment score of 0.93 beat Shoulder Innovations' score of 0.00 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shoulder Innovations
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kestra Medical Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Shoulder Innovations has a net margin of -81.78% compared to Kestra Medical Technologies' net margin of -171.87%. Shoulder Innovations' return on equity of -35.11% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Shoulder Innovations-81.78% -35.11% -20.58%
Kestra Medical Technologies -171.87%-65.49%-46.39%

Shoulder Innovations presently has a consensus target price of $21.00, indicating a potential upside of 49.79%. Kestra Medical Technologies has a consensus target price of $27.40, indicating a potential upside of 49.81%. Given Kestra Medical Technologies' higher probable upside, analysts plainly believe Kestra Medical Technologies is more favorable than Shoulder Innovations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shoulder Innovations
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Shoulder Innovations has higher earnings, but lower revenue than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shoulder Innovations$47.32M6.14-$40.36M-$166.96N/A
Kestra Medical Technologies$83.72M12.75-$113.81M-$3.96N/A

Summary

Shoulder Innovations beats Kestra Medical Technologies on 7 of the 12 factors compared between the two stocks.

How does Shoulder Innovations compare to BioLife Solutions?

BioLife Solutions (NASDAQ:BLFS) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

BioLife Solutions has a net margin of -2.80% compared to Shoulder Innovations' net margin of -81.78%. BioLife Solutions' return on equity of 1.81% beat Shoulder Innovations' return on equity.

Company Net Margins Return on Equity Return on Assets
BioLife Solutions-2.80% 1.81% 1.65%
Shoulder Innovations -81.78%-35.11%-20.58%

93.2% of BioLife Solutions shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

BioLife Solutions has higher revenue and earnings than Shoulder Innovations. BioLife Solutions is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLife Solutions$101.66M13.06-$4.59M-$0.08N/A
Shoulder Innovations$47.32M6.14-$40.36M-$166.96N/A

In the previous week, BioLife Solutions had 9 more articles in the media than Shoulder Innovations. MarketBeat recorded 11 mentions for BioLife Solutions and 2 mentions for Shoulder Innovations. BioLife Solutions' average media sentiment score of 0.29 beat Shoulder Innovations' score of 0.00 indicating that BioLife Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioLife Solutions
2 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Shoulder Innovations
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BioLife Solutions presently has a consensus price target of $32.00, indicating a potential upside of 17.73%. Shoulder Innovations has a consensus price target of $21.00, indicating a potential upside of 49.79%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts clearly believe Shoulder Innovations is more favorable than BioLife Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLife Solutions
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Shoulder Innovations
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Summary

BioLife Solutions beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to iRadimed?

Shoulder Innovations (NYSE:SI) and iRadimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

iRadimed has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shoulder Innovations$47.32M6.14-$40.36M-$166.96N/A
iRadimed$83.81M13.41$22.48M$1.8348.04

iRadimed has a net margin of 27.36% compared to Shoulder Innovations' net margin of -81.78%. iRadimed's return on equity of 24.48% beat Shoulder Innovations' return on equity.

Company Net Margins Return on Equity Return on Assets
Shoulder Innovations-81.78% -35.11% -20.58%
iRadimed 27.36%24.48%21.25%

92.3% of iRadimed shares are owned by institutional investors. 29.0% of Shoulder Innovations shares are owned by company insiders. Comparatively, 36.8% of iRadimed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Shoulder Innovations presently has a consensus price target of $21.00, suggesting a potential upside of 49.79%. iRadimed has a consensus price target of $120.00, suggesting a potential upside of 36.50%. Given Shoulder Innovations' higher probable upside, research analysts clearly believe Shoulder Innovations is more favorable than iRadimed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shoulder Innovations
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
iRadimed
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

In the previous week, iRadimed had 2 more articles in the media than Shoulder Innovations. MarketBeat recorded 4 mentions for iRadimed and 2 mentions for Shoulder Innovations. iRadimed's average media sentiment score of 0.42 beat Shoulder Innovations' score of 0.00 indicating that iRadimed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shoulder Innovations
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
iRadimed
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

iRadimed beats Shoulder Innovations on 14 of the 16 factors compared between the two stocks.

Get Shoulder Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for SI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SI vs. The Competition

MetricShoulder InnovationsSurgical, Medical, And Dental Instruments And Supplies IndustryMedical SectorNYSE Exchange
Market Cap$290.78M$2.55B$6.25B$23.15B
Dividend YieldN/AN/A2.69%4.09%
P/E Ratio-0.082.0621.0731.23
Price / Sales6.1480.12556.3214.76
Price / CashN/A3.5442.3124.78
Price / Book2.056.699.784.70
Net Income-$40.36M-$69.38M$3.56B$1.07B
7 Day Performance-6.57%-1.75%-0.18%-0.15%
1 Month Performance3.74%-4.47%4.95%0.75%
1 Year PerformanceN/A47.68%28.44%26.30%

Shoulder Innovations Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SI
Shoulder Innovations
3.9445 of 5 stars
$14.02
+0.1%
$21.00
+49.8%
N/A$290.78M$47.32MN/A61
COIN
Coinbase Global
4.2801 of 5 stars
$189.03
+3.7%
$252.10
+33.4%
-29.5%$48.02B$7.18B71.064,951
INSP
Inspire Medical Systems
4.3749 of 5 stars
$41.46
-3.7%
$81.84
+97.4%
-69.5%$1.24B$915.25M9.231,333
KMTS
Kestra Medical Technologies
2.5606 of 5 stars
$21.26
+0.0%
$27.40
+28.9%
-9.0%$1.24B$59.81MN/A300
BLFS
BioLife Solutions
2.4168 of 5 stars
$24.92
-1.3%
$32.00
+28.4%
+32.9%$1.23B$96.21MN/A440

Related Companies and Tools


This page (NYSE:SI) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners